Literature DB >> 22085601

First Neisseria gonorrhoeae strain with resistance to cefixime causing gonorrhoea treatment failure in Austria, 2011.

M Unemo1, D Golparian, A Stary, A Eigentler.   

Abstract

We describe the first cefixime-resistant Neisseria gonorrhoeae strain in Austria that caused treatment failure.It follows the first five cases in Europe of cefixime treatment failure, reported in Norway in 2010 and the United Kingdom in 2011. Effective treatment of gonorrhoea is crucial for public health control and, at present, requires substantially enhanced awareness, more frequent test-of-cure, interaction with experts after therapeutic failure, tracing and therapy of contacts, and surveillance of gonococcal antimicrobial resistance and treatment failures worldwide.

Entities:  

Mesh：

Substances：

Year:  2011        PMID： 22085601

Source DB:  PubMed          Journal:  Euro Surveill        ISSN： 1025-496X


  57 in total

Review 1.  The use of cephalosporins for gonorrhea: an update on the rising problem of resistance.

Authors:  Juliet E Stoltey; Pennan M Barry
Journal:  Expert Opin Pharmacother       Date:  2012-05-30       Impact factor: 3.889

2.  The novel 2016 WHO Neisseria gonorrhoeae reference strains for global quality assurance of laboratory investigations: phenotypic, genetic and reference genome characterization.

Authors:  Magnus Unemo; Daniel Golparian; Leonor Sánchez-Busó; Yonatan Grad; Susanne Jacobsson; Makoto Ohnishi; Monica M Lahra; Athena Limnios; Aleksandra E Sikora; Teodora Wi; Simon R Harris
Journal:  J Antimicrob Chemother       Date:  2016-07-17       Impact factor: 5.790

3.  Changing antimicrobial susceptibility and molecular characterisation of Neisseria gonorrhoeae isolates in Guangdong, China: in a background of rapidly rising epidemic.

Authors:  Xiaolin Qin; Yunhu Zhao; Wei Chen; Xingzhong Wu; Sanmei Tang; Guozhou Li; Yu Yuqi; Wenling Cao; Xiaofeng Liu; Jinmei Huang; Jieyi Yang; Wentao Chen; Weiming Tang; Heping Zheng
Journal:  Int J Antimicrob Agents       Date:  2019-08-16       Impact factor: 5.283

4.  Sexually transmitted diseases treatment guidelines, 2015.

Authors:  Kimberly A Workowski; Gail A Bolan
Journal:  MMWR Recomm Rep       Date:  2015-06-05

Review 5.  Antimicrobial resistance in Neisseria gonorrhoeae in the 21st century: past, evolution, and future.

Authors:  Magnus Unemo; William M Shafer
Journal:  Clin Microbiol Rev       Date:  2014-07       Impact factor: 26.132

6.  Gonorrhea: Treatment update for an increasingly resistant organism.

Authors:  Jolanta Piszczek; Renée St Jean; Yasmin Khaliq
Journal:  Can Pharm J (Ott)       Date:  2015-03

7.  Neisseria gonorrhoeae strain with high-level resistance to spectinomycin due to a novel resistance mechanism (mutated ribosomal protein S5) verified in Norway.

Authors:  Magnus Unemo; Daniel Golparian; Vegard Skogen; Anne Olaug Olsen; Harald Moi; Gaute Syversen; Stig Ove Hjelmevoll
Journal:  Antimicrob Agents Chemother       Date:  2012-11-26       Impact factor: 5.191

8.  Accuracy and reproducibility of the Etest to detect drug-resistant Neisseria gonorrhoeae to contemporary treatment.

Authors:  John R Papp; Marie-Claire Rowlinson; Norman P O'Connor; Jason Wholehan; Jafar H Razeq; Anita Glennen; Dapne Ware; Peter C Iwen; Lillian V Lee; Celia Hagan
Journal:  J Med Microbiol       Date:  2017-12-08       Impact factor: 2.472

9.  Genome sequencing of a Neisseria gonorrhoeae isolate of a successful international clone with decreased susceptibility and resistance to extended-spectrum cephalosporins.

Authors:  David Hess; Abel Wu; Daniel Golparian; Sarah Esmaili; Will Pandori; Emilee Sena; Jeffrey D Klausner; Pennan Barry; Magnus Unemo; Mark Pandori
Journal:  Antimicrob Agents Chemother       Date:  2012-08-20       Impact factor: 5.191

Review 10.  Expedited partner therapy for sexually transmitted infections.

Authors:  Matthew Hogben; Sarah Kidd; Gale R Burstein
Journal:  Curr Opin Obstet Gynecol       Date:  2012-10       Impact factor: 1.927
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.